Skip to main content
. 2021 Dec 2;6(1):bvab169. doi: 10.1210/jendso/bvab169

Figure 3.

Figure 3.

Δ Glycated hemoglobin A1c (HbA1c) following the curative procedure for Cushing syndrome. A, Δ HbA1c in all patients (n = 130). B, Δ HbA1c in 42 patients in whom hyperglycemia management was not changed (including those on no medications). C, Δ HbA1c in 71 patients in whom the intensity of hyperglycemia management was decreased (decrease in dose or number of medications). D, Δ HbA1c in 17 patients in whom the intensity of hyperglycemia management was increased (increase in dose or number of medications, new start of medications).